Business Description
Indo US Bio-Tech Ltd
ISIN : INE250Z01010
Share Class Description:
BOM:541304: Ordinary SharesCompare
Compare
Traded in other countries / regions
541304.India IPO Date
2018-05-11Description
Indo US Bio-Tech Ltd is engaged in the trading of agricultural seeds. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of agriculture crops. The company's product categories include vegetables; cotton seeds; oilseeds; spices seeds; pulses seeds and cereals seeds. The company has two segments which include Agricultural Activities and Trading Activities out of which it generates the key revenue from the Agricultural Activities.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.22 | |||||
| Debt-to-EBITDA | 1.06 | |||||
| Interest Coverage | 9.88 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 21.17 | |||||
| Beneish M-Score | -1.43 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.7 | |||||
| 3-Year EBITDA Growth Rate | 14.6 | |||||
| 3-Year EPS without NRI Growth Rate | 6.8 | |||||
| 3-Year FCF Growth Rate | -42.8 | |||||
| 3-Year Book Growth Rate | 9.4 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.57 | |||||
| 9-Day RSI | 56.61 | |||||
| 14-Day RSI | 52.54 | |||||
| 6-1 Month Momentum % | 17.77 | |||||
| 12-1 Month Momentum % | 21.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.74 | |||||
| Quick Ratio | 2.52 | |||||
| Cash Ratio | 0.08 | |||||
| Days Inventory | 199.87 | |||||
| Days Sales Outstanding | 95.23 | |||||
| Days Payable | 10.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward Dividend Yield % | 0.1 | |||||
| 3-Year Average Share Buyback Ratio | -11.3 | |||||
| Shareholder Yield % | -0.47 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 28.64 | |||||
| Operating Margin % | 17.18 | |||||
| Net Margin % | 13.85 | |||||
| FCF Margin % | 8.94 | |||||
| ROE % | 21.58 | |||||
| ROA % | 16.36 | |||||
| ROIC % | 20.52 | |||||
| ROC (Joel Greenblatt) % | 21.19 | |||||
| ROCE % | 22.89 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 44.41 | |||||
| PE Ratio without NRI | 44.08 | |||||
| Shiller PE Ratio | 93.04 | |||||
| PEG Ratio | 1.61 | |||||
| PS Ratio | 6.13 | |||||
| PB Ratio | 7.38 | |||||
| Price-to-Tangible-Book | 7.39 | |||||
| Price-to-Free-Cash-Flow | 68.77 | |||||
| Price-to-Operating-Cash-Flow | 63.8 | |||||
| EV-to-EBIT | 39.51 | |||||
| EV-to-EBITDA | 37.41 | |||||
| EV-to-Revenue | 6.29 | |||||
| EV-to-FCF | 70.13 | |||||
| Price-to-DCF (Earnings Based) | 1.69 | |||||
| Price-to-DCF (FCF Based) | 6.91 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.52 | |||||
| Price-to-Graham-Number | 3.8 | |||||
| Price-to-Net-Current-Asset-Value | 8.82 | |||||
| Earnings Yield (Greenblatt) % | 2.54 | |||||
| FCF Yield % | 1.46 | |||||
| Forward Rate of Return (Yacktman) % | 19.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Indo US Bio-Tech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 847.703 | ||
| EPS (TTM) (₹) | 5.83 | ||
| Beta | 0.76 | ||
| Volatility % | 38.57 | ||
| 14-Day RSI | 52.54 | ||
| 14-Day ATR (₹) | 15.943166 | ||
| 20-Day SMA (₹) | 252.13 | ||
| 12-1 Month Momentum % | 21.65 | ||
| 52-Week Range (₹) | 180 - 349.8 | ||
| Shares Outstanding (Mil) | 20.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Indo US Bio-Tech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Indo US Bio-Tech Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Indo US Bio-Tech Ltd Frequently Asked Questions
What is Indo US Bio-Tech Ltd(BOM:541304)'s stock price today?
The current price of BOM:541304 is ₹258.85. The 52 week high of BOM:541304 is ₹349.80 and 52 week low is ₹180.00.
When is next earnings date of Indo US Bio-Tech Ltd(BOM:541304)?
The next earnings date of Indo US Bio-Tech Ltd(BOM:541304) is .
Does Indo US Bio-Tech Ltd(BOM:541304) pay dividends? If so, how much?
Indo US Bio-Tech Ltd(BOM:541304) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers